Colon cancer is a heavily studied disease—and for good reason. It is one of the leading causes of cancer-related deaths worldwide, and its numbers are on the rise, from 500,00 deaths in 1990 to 700,000 in 2010.
Mar 16, 2015
0
13
Detecting cancer early before it spreads throughout the body can be lifesaving. This is why doctors recommend regular screening for several common cancer types, using a variety of methods. Colonoscopies, for example, screen ...
Nov 1, 2022
0
32
Tales from the crypt are supposed to be scary, but new research from Vanderbilt University, the HudsonAlpha Institute for Biotechnology and colleagues shows that crypts can be places of renewal too: intestinal crypts, that ...
Mar 30, 2012
0
0
New research at Washington University School of Medicine in St. Louis and Vanderbilt University Medical Center in Nashville has implicated a poorly understood protein called PLAC8 in the spread of colon cancer.
Apr 1, 2014
0
0
Researchers in Texas A&M University's College of Agriculture and Life Sciences have proposed a "unified" way to explain the function of dietary bioactives in suppressing cancer-causing cell signaling.
Jul 24, 2015
0
21
(Medical Xpress)—The engineered antibody MPDL3280A, which targets a protein called programmed death-ligand 1 (PD-L1), was safe and effective for several cancers, according to phase I study results presented at the AACR ...
Apr 10, 2013
0
1
Phthalates are commonly used to make products—including artificial leather, footwear, plastic food packaging, and personal care products—more flexible or stable. In particular, di-isononyl phthalate is incorporated in ...
Apr 6, 2022
0
1
After a recent University of Illinois study showed that injection of the soy peptide lunasin dramatically reduced colon cancer metastasis in mice, the researchers were eager to see how making lunasin part of the animals' ...
Jul 8, 2013
0
0
When the pharmaceutical industry develops new medicines – for example for cancer treatment – it is important to have detailed knowledge of the body's molecular response to the medicine.
Sep 19, 2013
0
0
(HealthDay)—The combination pill Lonsurf (trifluridine and tipiracil) has been approved by the U.S. Food and Drug Administration to treat advanced colon cancer for people who aren't responding to other treatments, the agency ...
Sep 23, 2015
0
11
